Skip to main content
SpringerLink
Log in

Conversion of surgically verified unresectable to resectable hepatocellular carcinoma

A report of 26 patients with subsequent resection

  • Clinical Observations
  • Published:
Chinese Journal of Cancer Research

Abstract

During the period 1978–1987, 255 patients with pathologically proven hepatocellular carcinoma (HCC) were determined by laparotomy to be unresectable, 155 (60.8%) out of them had their tumor mainly confined in right or left lobe and considered to be potentially resectable if remarkable tumor shrinkage appears after treatment. Second look operation was performed in 26 (16.8%) out of the 155 patients after marked reduction of tumor size, resection was done in all of these 26 patients. Triple or quadruple combination treatment with hepatic artery ligation (HAL), hepatic artery infusion (HAI) with chemotherapy, radiotherapy using linear accelerator, and radioimmunotherapy using 131-I antihuman HCC ferritin antibody yielded the highest conversion rate (29.8%, 14/47) as compared to double combination treatment with HAL+HAI, or cryosurgery+HAL (16.9%, 12/71) and single treatment with HAL or HAI or HAE (embolization) (0%, 0/37). The median tumor size of these 26 patients was reduced from 9.5 cm to 5.0 cm after combination treatment. The median interval between the first laparotomy and the subsequent resection was 5.0 (2–16) months. The survival rates calculated by life table method were: 1-year 86.5%, 2-year 74.3% and 3-year 74.3%. Nine cases have survival more than 3 years. Thus, multimodality combination treatment with subsequent resection might prolong survival significantly for some patients with unresectable HCC particularly confined in right lobe of a cirrhotic liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wu MC, et al. Hepatic resection or primary cancer. Chin Med J 1986; 99:175.

    PubMed  CAS  Google Scholar 

  2. 汤 钊猷, 余 业勤. 小肝癌及其远期结果. 中华 肿瘤杂志 1987;9:118.

    Google Scholar 

  3. Nakanishi Y, et al. Concept and problems of early stage of primary liver cancer. J Jpn Surg Soc 1985; 86:1082.

    CAS  Google Scholar 

  4. Lin TY, et al. Role of surgery in the treatment of primary carcinoma of the liver: a 31 years experience. Br J Surg 1987; 74:839.

    Article  PubMed  CAS  Google Scholar 

  5. Nagao T, et al. Hepatic resection for hepatocellular carcinoma. Ann Surg 1987; 205:33.

    Article  PubMed  CAS  Google Scholar 

  6. Tang ZY, et al. The changing role of surgery in the treatment of primary liver cancer. Semin Surg Oncol 1986; 2:103.

    Article  PubMed  CAS  Google Scholar 

  7. 余 业勤, 等. 大肝癌的分阶段治疗. 中华外科 杂志. 1983; 21:92.

    Google Scholar 

  8. Teitelbaum DH, et al. Fibrolamellar carcinoma of the liver, review of three cases and presentation of a characteristic set of tumor markers defining this tumor. Ann Surg 1985; 202:36.

    Article  PubMed  CAS  Google Scholar 

  9. Sitzmann JV, et al. Conversion by new treatment modalities of unresectable to resectable hepatocellular carcinoma. J Clin Oncol 1987; 5:1566.

    PubMed  CAS  Google Scholar 

  10. Chen H, Wu MC. Reoperative primary liver cancer report of 28 cases. Chin Med J 1987; 100:795.

    PubMed  CAS  Google Scholar 

  11. Herman RE, Lonsdale D. Chemotherapy, radiotherapy and hepatic lobectomy for hepatoblastoma in an infant, report of a survival. Surgery 1970; 68:383.

    Google Scholar 

  12. Exelby P, et al. Liver tumors in children in particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey 1974. J Pediatr Surg 1975; 10:329.

    Article  PubMed  CAS  Google Scholar 

  13. Shafer AD, Selinkoff PM. Preoperative irradiation and chemotherapy for initially unresectable hepatoblastoma. J Pediatr Surg 1977; 12:1001.

    Article  PubMed  CAS  Google Scholar 

  14. Fegiz G, et al. A case report of hepatoblastoma treated by chemotherapy and hepatic lobectomy. World J Surg 1977; 1:407.

    Article  PubMed  CAS  Google Scholar 

  15. Toyosaka A, et al. Aggressive treatment for advanced hepatic cancer in children. J Jpn Surg Soc 1982; 83:901.

    Google Scholar 

  16. Mahour GH, et al. Improved survival in infants and children with primary malignant liver tumors. Am J Surg 1983; 146:236.

    Article  PubMed  CAS  Google Scholar 

  17. Danglass EC, et al. Effective therapy for metastatic/unresectable hepatoblastoma (HB). Proc Am Soc Clin Oncol 1987; 6:A841 (Abstr).

  18. Almersjo O, et al. Hepatic artery ligation as pretreatment for liver resection of metastatic cancer. Revue Surg 1966; 23:37.

    Google Scholar 

  19. Gayral F, et al. Response of colorectal metastatic cancer to hepatic intra-arterial chemotherapy. Histopathologic evaluation in three cases of secondary hepatic resection. Gastroenterol Clin Biol 1987; 11:88.

    PubMed  CAS  Google Scholar 

  20. Tang ZY, et al. Tumor imaging and targeting therapy for hepatocellular carcinoma, preliminary results of experimental and clinical studies. Chin Med J 1986; 99:855.

    PubMed  CAS  Google Scholar 

  21. Looney WB. Alternating chemotherapy and radiotherapy. NCI Monogr 1988; 6:85.

    PubMed  Google Scholar 

  22. Zhou XD, et al. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases. Cancer 1988; 61:1889.

    Article  PubMed  CAS  Google Scholar 

  23. Tang ZY, Yu YQ. Long-term survival of hepatocellular carcinoma with reference to the role of early resection, multioperation and multimodality treatment. Gann Monogr Cancer Res 1986; 31:185.

    Google Scholar 

  24. Okuda K, Ohnishi K. Prognosis of hepatocellular carcinoma. In: Okuda K, Ishak KG (eds): Neoplasms of the liver. Tokyo: Springer. 1987; 407–415.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Cancer Institute, Shanghai Medical University, China

    Tang Zhaoyou, Yu Yeqin, Ma Zengchen, Yang Rong, Zhou Xinda, Liu Kangda, Lu Jizhen, Bao Yanming, Lin Zhiying & Yang Binghui

Authors
  1. Tang Zhaoyou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yu Yeqin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ma Zengchen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Rong
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhou Xinda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Liu Kangda
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lu Jizhen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bao Yanming
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lin Zhiying
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yang Binghui
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, Z., Yu, Y., Ma, Z. et al. Conversion of surgically verified unresectable to resectable hepatocellular carcinoma. Chinese Journal of Cancer Research 1, 41–47 (1989). https://doi.org/10.1007/BF02684817

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02684817

Keywords

Search

Navigation